Chang Wang | Pharmacokinetic | Best Researcher Award

Published on by Global Academic Awards

Mr. Chang Wang | Pharmacokinetic | Best Researcher Award

Mr. Chang Wang, The Second Hospital & Clinical Medical School, Lanzhou University, China

Mr. Chang Wang is a dedicated Pharmacist In-Charge at Lanzhou University’s Second Hospital. He holds a Doctor of Medicine candidacy in Traditional Chinese Pharmacy from Gansu University of Chinese Medicine. His expertise spans therapeutic drug monitoring and clinical pharmacology, with significant contributions in drug interactions and high-altitude pharmacology. Mr. Wang has published widely, including in the Journal of Chromatography B and Journal of Mass Spectrometry. He has received the First Prize for Military Scientific and Technological Progress and is an active member of several professional societies, including the International Association of Therapeutic Drug Monitoring. 💊📚

 

Publication Profile

Scopus

Educational Background 🎓

Mr. Chang Wang is currently pursuing a Doctor of Medicine in Traditional Chinese Pharmacy at Gansu University of Chinese Medicine (2024-present). He earned his Master of Pharmacy from Lanzhou University, School of Pharmacy (2012-2015), where he deepened his expertise in pharmaceutical sciences. Prior to that, he completed his Bachelor of Science in Pharmacy at Lanzhou University, School of Pharmacy (2008-2012). Mr. Wang’s solid educational foundation has enabled him to advance his career as a clinical pharmacist and contribute significantly to the field of therapeutic drug monitoring and clinical pharmacology. 💊📚

 

 

Academic Positions 🏥

Mr. Chang Wang currently serves as the Pharmacist In-Charge at the Department of Pharmacy in the Second Hospital & Clinical Medical School, Lanzhou University (2019-present), where he plays a key role in clinical pharmacy operations. Prior to this, he worked as a Pharmacist at the Department of Pharmacy, 940 Hospital, Joint Service Support Force of the Chinese People’s Liberation Army (2015-2018). His extensive experience in both academic and military healthcare settings has strengthened his expertise in pharmacology, therapeutic drug monitoring, and clinical pharmacy practice. 💉💊

 

 

Research Focus

Mr. Chang Wang’s research primarily revolves around pharmacology, drug monitoring, and pharmacokinetics. His work includes developing advanced analytical methods, such as UPLC–MS/MS for quantifying drugs like polymyxins and caspofungin for therapeutic drug monitoring. He has contributed significantly to understanding the regulation mechanisms of drug-metabolizing enzymes and transporters, especially in hypoxia and high-altitude environments. His studies also explore the impact of intestinal microflora on drug metabolism, renal excretion, and drug efficacy under varying physiological conditions. Mr. Wang’s research is pivotal in advancing personalized medicine and drug therapy. 💉🧬

 

 

Publication Top Notes

  • Development and validation of a UPLC–MS/MS method for simultaneous quantification of polymyxins and caspofungin in human plasma for therapeutic drug monitoring – Wu, T., Pu, L., Liu, W., Wang, C., Qiu, W. (2025) 📅
  • Modulation of drug-metabolizing enzymes and transporters under hypoxia environment – Min, Q., Feng, S.-L., Lu, H., Wang, R., Zhang, J.-H., Wang, C. (2019) – Cited by 3 📖
  • Effects of intestinal microflora on drug metabolism – Chen, Y.-Y., Wang, R., Zhang, J.-H., Wang, C., Sun, Y.-M. (2019) – Cited by 5 💊
  • Potential regulation mechanisms of P-gp in the blood-brain barrier in hypoxia – Ding, Y., Wang, R., Zhang, J., Wang, C., Yuan, X. (2019) – Cited by 15 🧠
  • Plasma proteomic study of acute mountain sickness susceptible and resistant individuals – Lu, H., Wang, R., Li, W., Sun, Y., Jia, Z. (2018) – Cited by 19 ⛰️
  • Research progress of long chain non-coding RNA H19 in anoxic environment mechanism – Yue, X., Wang, R., Li, W., Lu, H., Zhang, J. (2018) – Cited by 1 🧬
  • Interaction of amoxicillin and nifedipine mediated by intestinal flora – Zhang, J.-H., Zhang, J.-M., Wang, R., Zhao, A.-P., Jia, Z.-P. (2018) – Cited by 5 💊
  • Research progress on clinical gene polymorphism of clopidogrel resistance – Sun, Y.-M., Cui, M.-X., Li, W.-B., Wang, C., Wang, R. (2018) – Cited by 3 🧬
  • Evaluation of renal excretion and pharmacokinetics of furosemide in rats after acute exposure to high altitude at 4300 m – Luo, B., Li, J., Yang, T., Zhao, A., Wang, R. (2018) – Cited by 11 🌄
  • Advances of studies on effect of drug transporter under hypoxia – Zhang, M.-X., Wang, R., Xu, W.-B., Liu, J.-J., Jia, Z.-P. (2018) – Cited by 5 💉

 

 

HECTOR ABELARDO OCAMPO | Pharmaceutical Science | Excellence in Research

Published on by Global Academic Awards

Dr. HECTOR ABELARDO OCAMPO | Pharmaceutical Science | Excellence in Research

Dr. HECTOR ABELARDO OCAMPO, Instituto Politécnico Nacional, Mexico

Dr. Héctor Abelardo González Ocampo is a dedicated researcher and full-time professor at the Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional, focusing on sustainable aquaculture technologies. His innovative work includes developing microencapsulated phenolic extracts as antioxidant and immunostimulant additives in aquaculture diets. He holds several patents related to biotechnological additives and environmental impact. Dr. González supervises master’s and doctoral students in natural resource management and biotechnology, contributing significantly to academic development. His recent graduates have explored topics related to environmental health risks associated with marine species. 🌱🐟📚

Publication Profile

Google Scholar

Academic Experience and Contributions

Dr. Ocampo has a substantial teaching portfolio. He imparts knowledge in environmental impact and ecotoxicology to graduate students, thereby shaping the next generation of researchers in environmental sciences. His commitment to education ensures that his research impacts future leaders in sustainable practices and policies.

 

Conclusion

Dr. Héctor Abelardo Ocampo’s multifaceted expertise in sustainable aquaculture technologies, public health risk assessment, and his strong academic and patent record positions him as an exemplary candidate for the Research for Best Researcher Award. His work not only advances scientific knowledge but also contributes to practical solutions in environmental sustainability and public health safety, aligning perfectly with the award’s objectives.

Publication Top Notes  

  • Las áreas naturales protegidas de México 🌳 | Cited by: 91 | Year: 2014
  • The prebiotic inulin increases the phenoloxidase activity and reduces the prevalence of WSSV in whiteleg shrimp (Litopenaeus vannamei) cultured under laboratory conditions 🍤 | Cited by: 77 | Year: 2012
  • Effect of inulin and probiotic bacteria on growth, survival, immune response, and prevalence of white spot syndrome virus (WSSV) in Litopenaeus vannamei 🦠 | Cited by: 57 | Year: 2013
  • Microbial immunostimulants reduce mortality in whiteleg shrimp (Litopenaeus vannamei) challenged with Vibrio sinaloensis strains ⚠️ | Cited by: 54 | Year: 2011
  • Mangrove forest and artisanal fishery in the southern part of the Gulf of California, Mexico 🌊 | Cited by: 51 | Year: 2013
  • Growth, survival, and superoxide dismutase activity in juvenile Crassostrea corteziensis (Hertlein, 1951) treated with probiotics 🦪 | Cited by: 44 | Year: 2009
  • Human health risk assessment of pesticide residues in snappers (Lutjanus) fish from the Navachiste Lagoon complex, Mexico ⚠️ | Cited by: 38 | Year: 2015
  • Protective effect of microbial immunostimulants and antiviral plants against WSSV in Litopenaeus vannamei cultured under laboratory conditions 🌱 | Cited by: 37 | Year: 2014
  • Dietary microorganism and plant effects on the survival and immune response of Litopenaeus vannamei challenged with the white spot syndrome virus 🍃 | Cited by: 35 | Year: 2011
  • Isolation and characterization of infectious Vibrio sinaloensis strains from the Pacific shrimp Litopenaeus vannamei (Decapoda: Penaeidae) 🔬 | Cited by: 34 | Year: 2012